Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Bryan, Wittmann"'
Autor:
Adam D Kennedy, Lisa Ford, Bryan Wittmann, Jesse Conner, Jacob Wulff, Matthew Mitchell, Anne M Evans, Douglas R Toal
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249797 (2021)
IntroductionAnalysis of blood for the evaluation of clinically relevant biomarkers requires precise collection and sample handling by phlebotomists and laboratory staff. An important consideration for the clinical application of metabolomics are the
Externí odkaz:
https://doaj.org/article/e2d1db67b3934997bbe2525e1c2b71fa
Publikováno v:
Toxics, Vol 10, Iss 2, p 56 (2022)
Despite the impressive safety of gadolinium (Gd)-based contrast agents (GBCAs), a small number of patients report the onset of new, severe, ongoing symptoms after even a single exposure—a syndrome termed Gadolinium Deposition Disease (GDD). Mitocho
Externí odkaz:
https://doaj.org/article/8af0b64191f54bbf9269db476df39a63
Autor:
Lisa, Ford, Matthew, Mitchell, Jacob, Wulff, Annie, Evans, Adam, Kennedy, Sarah, Elsea, Bryan, Wittmann, Douglas, Toal
Publikováno v:
Advances in clinical chemistry. 107
Metabolism is a highly regulated process that provides nutrients to cells and essential building blocks for the synthesis of protein, DNA and other macromolecules. In healthy biological systems, metabolism maintains a steady state in which the concen
Autor:
Lisa Ford, Matthew Mitchell, Jacob Wulff, Annie Evans, Adam Kennedy, Sarah Elsea, Bryan Wittmann, Douglas Toal
Publikováno v:
Advances in Clinical Chemistry ISBN: 9780323988476
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::becc75e9475338f00da9bb5bd5bba0c5
https://doi.org/10.1016/bs.acc.2021.09.001
https://doi.org/10.1016/bs.acc.2021.09.001
Autor:
Lisa A. Ford, Bryan Wittmann, Luke A. D. Miller, Kelli Goodman, Anne M. Evans, Douglas R. Toal, Adam D. Kennedy, Matthew W. Mitchell
Publikováno v:
Metabolomics. 17
Clinical metabolomics has utility as a screen for inborn errors of metabolism (IEM) and variant classification in patients with rare disease. It is important to understand and characterize preanalytical factors that influence assay performance during
Autor:
Kelli, Goodman, Matthew, Mitchell, Anne M, Evans, Luke A D, Miller, Lisa, Ford, Bryan, Wittmann, Adam D, Kennedy, Douglas, Toal
Publikováno v:
Metabolomics : Official journal of the Metabolomic Society. 17(3)
Clinical metabolomics has utility as a screen for inborn errors of metabolism (IEM) and variant classification in patients with rare disease. It is important to understand and characterize preanalytical factors that influence assay performance during
Publikováno v:
Cancer Medicine
Urothelial carcinoma is the most common form of bladder cancer, but pathway changes that occur with stage‐wise progression have not been well defined. We used a metabolomics approach to identify potential metabolic pathways uniquely altered in norm
Autor:
Douglas R. Toal, Lisa A. Ford, Anne M. Evans, Bryan Wittmann, Jesse Conner, Adam D. Kennedy, Jacob Wulff, Matthew D. Mitchell
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 4, p e0249797 (2021)
PLoS ONE, Vol 16, Iss 4, p e0249797 (2021)
Introduction Analysis of blood for the evaluation of clinically relevant biomarkers requires precise collection and sample handling by phlebotomists and laboratory staff. An important consideration for the clinical application of metabolomics are the
Autor:
Yuji Tada, James West, Anna R. Hemnes, Nobuhiro Tanabe, Linda Robinson, Joshua P. Fessel, Koichiro Tatsumi, Rizwan Hamid, Bryan Wittmann, Tom W Blackwell
Publikováno v:
Pulmonary Circulation
Pulmonary arterial hypertension (PAH) is a progressive and fatal disease of the lung vasculature for which the molecular etiologies are unclear. Specific metabolic alterations have been identified in animal models and in PAH patients, though existing
Autor:
Luke A. D. Miller, Adam D. Kennedy, Douglas R. Toal, Lonergan Shaun, Anne M. Evans, Sarah H. Elsea, Kirk L. Pappan, Bryan Wittmann
Publikováno v:
Journal of Mass Spectrometry. 53:ii-ii
Metabolomics is the untargeted measurement of the metabolome, which is composed of the complement of small molecules detected in a biological sample. As such, metabolomic analysis produces a global biochemical phenotype. It is a technology that has b